Reporte zur Charge UT7323JA

Symptomtext

The mother received vaccine during pregnancy, no AE; Initial information was received on 16-Sep-2021 regarding an unsolicited valid non-serious case from a physician. This case involves a 31-year-old female patient who was exposed to vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] during pregnancy (Exposure during pregnancy). Data regarding this pregnancy were received prospectively, i.e., before pregnancy outcome was known. The date of last menstrual period was reported as 15-May-2021. The estimated due date is 27-Feb-2022. It was unknown if the patient had any medical history, concomitant disease or risk factor Medical treatment(s), vaccination(s), concomitant medications and family history were not provided. On 15-Sep-2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot UT7323JA, expiry date: 30-Jun-2022) via unknown route in unknown administration site for prophylactic vaccination. It was a case of vaccine exposure during pregnancy (latency same day). The mother did not experience any adverse events during vaccine. At time of reporting, the outcome of the pregnancy is unknown.